Kobari T, Iguro Y, Ito T, Namekawa H, Kato Y, Yamada S
Xenobiotica. 1985 Jul;15(7):605-13. doi: 10.3109/00498258509045890.
Single oral and intramuscular doses of 14C-sultopride to rat, rabbit and dog and single oral doses of sultopride to human volunteers were well absorbed. Mean blood levels of total 14C peaked at 0.4-1.1 h and declined with half-lives of 2, 1.5 and 3 h in rat, rabbit and dog, respectively. In man mean serum levels of unchanged drug attained a peak at 1.5 h and were eliminated with a half-life of 3.6 h. Highest concn. of radioactivity were found in rat liver, kidney, hypophysis, submaxillary gland and gastrointestinal tract. The concn. in the cerebrum and cerebellum were low. 14C-Sultopride passed through the placental barrier. 14C-Sultopride was poorly bound to plasma proteins (less than 25% bound) in all species. Repeated doses of the drug slightly increased the blood and tissue levels of 14C in the rat. Most of the dose was eliminated via the kidneys in all species. Male rats excreted larger amounts of 14C into bile and faeces. A high ratio of A.U.C. (milk)/(blood) (c. 3.5) was found in the lactating rat.
给大鼠、兔子和狗单次口服及肌内注射14C-舒必利,给人类志愿者单次口服舒必利后,药物吸收良好。大鼠、兔子和狗体内总14C的平均血药浓度分别在0.4 - 1.1小时达到峰值,并分别以2小时、1.5小时和3小时的半衰期下降。在人体中,未变化药物的平均血清浓度在1.5小时达到峰值,并以3.6小时的半衰期消除。放射性最高浓度出现在大鼠的肝脏、肾脏、垂体、颌下腺和胃肠道。大脑和小脑中的浓度较低。14C-舒必利可穿过胎盘屏障。在所有物种中,14C-舒必利与血浆蛋白的结合率较低(结合率小于25%)。大鼠重复给药后,药物使体内14C的血药浓度和组织浓度略有升高。所有物种中,大部分剂量经肾脏排泄。雄性大鼠向胆汁和粪便中排泄的14C量更多。在泌乳大鼠中发现,药物的A.U.C.(乳汁)/(血液)比值较高(约为3.5)。